Status:
NOT_YET_RECRUITING
Preoperative Pregabalin vs Gabapentin in Elderly Undergoing Surgry,Controlled Trial
Lead Sponsor:
Cairo University
Conditions:
Anxiety
Anxiety Disorder (Panic Disorder or GAD)
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Several studies have evaluated the efficacy of pregabalin in reducing preoperative anxiety, with inconsistent results. Similarly, inconclusive results have been reported regarding gabapentin and its e...
Eligibility Criteria
Inclusion
- This study will include :
- geriatric patients, aged 65 years or older,
- Both sex,
- scheduled for elective abdominopelvic surgery with regional anesthesia
- American Society of Anesthesiologists (ASA) physical status I or II.
Exclusion
- We will exclude patients with any of the following:
- history of allergy to gabapentin or pregabalin;
- current use of gabapentin or pregabalin for other indications
- history of chronic pain or chronic daily use of analgesics; a
- history of epilepsy, other neurological disorders, cognitive impairment, or severe psychiatric disorders;
- severe cardiovascular or respiratory diseases;
- impaired renal function; and a history of drug or alcohol abuse.
- patients with anticipated prolonged duration of surgery for more than two hours
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT07000201
Start Date
September 15 2025
End Date
December 30 2025
Last Update
July 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasralaini medical school
Cairo, Giza Governorate, Egypt, 12613